ESAs Increase Blood Clot Risk

Drugs to treat anemia in older cancer patients increased their risk of blood clots and didn’t reduce the need for blood transfusions. Among over 56,000 cancer patients 65 and older treated in community settings from 1991 through 2002, 27 percent received an erythropoiesis-stimulating agent (ESA).   Fifteen percent of those who got ESAs developed a blood clot…  Read More